N- (1-benzyl-2-oxo-2- (1-piperazinyl) ethyl) - 1-piperidincarboxamid-derivatives and related compounds use as CGRPantagonists for treating a headache

Details for Australian Patent Application No. 2004203916 (hide)

Owner Boehringer Ingelheim International GmbH

Inventors Mueller, Stephan Georg; Rudolf, Klaus; Schindler, Marcus; Stenkamp, Dirk; Bauer, Eckhart; Gerlach, Kai; Hurnaus, Rudolf

Agent Davies Collison Cave

Pub. Number AU-A-2004203916

PCT Pub. Number WO2004/063171

Priority 103 00 973.6 14.01.03 DE

Filing date 9 January 2004

Wipo publication date 29 July 2004

International Classifications

C07D 239/80 Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

A61K 031/54 - having six-membered rings with at least one nitrogen and at least one sulfur as the ring hetero atoms, e.g. sulthiame

C07D 243/02 Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms

C07D 471/04 Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups

C07D 285/36 Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

C07D 403/12 Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

C07D 417/12 Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group

C07D 405/12 Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom

A61K 031/505 - Pyrimidines

A61K 031/55 - having seven-membered rings, e.g. azelastine, pentylenetetrazole

A61K 031/435 - having six-membered rings with one nitrogen as the only ring hetero atom

Event Publications

18 August 2005 PCT application entered the National Phase

  PCT publication WO2004/063171 Priority application(s): WO2004/063171

24 January 2008 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004203918-Safety containers for biologically active substances and method for producing said container

2004203912-Stabilization of thermoplastic nanocomposites